| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
27,098 |
22,924 |
$2.64M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
32,777 |
29,022 |
$1.83M |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,901 |
4,531 |
$1.46M |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,230 |
6,708 |
$1.34M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,283 |
7,629 |
$1.24M |
| 81001 |
|
18,246 |
16,080 |
$817K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,745 |
1,550 |
$650K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,305 |
3,093 |
$498K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,864 |
4,644 |
$438K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,144 |
3,365 |
$328K |
| 36415 |
Collection of venous blood by venipuncture |
3,307 |
3,029 |
$218K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,503 |
4,074 |
$189K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,528 |
4,224 |
$172K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,491 |
3,963 |
$172K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,061 |
1,862 |
$169K |
| 71046 |
Radiologic examination, chest; 2 views |
4,121 |
3,839 |
$164K |
| 87081 |
|
1,458 |
1,366 |
$151K |
| 73610 |
|
1,126 |
1,045 |
$146K |
| 81025 |
|
8,272 |
7,448 |
$146K |
| 73630 |
|
1,436 |
1,333 |
$142K |
| 71045 |
Radiologic examination, chest; single view |
8,991 |
7,906 |
$139K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,037 |
966 |
$132K |
| 87070 |
|
734 |
690 |
$121K |
| 76830 |
Ultrasound, transvaginal |
828 |
804 |
$114K |
| 73130 |
|
754 |
710 |
$111K |
| 87075 |
|
1,190 |
1,126 |
$109K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,670 |
3,403 |
$108K |
| 81003 |
|
1,363 |
1,227 |
$96K |
| 73562 |
|
1,213 |
1,147 |
$94K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,023 |
9,855 |
$86K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
869 |
858 |
$85K |
| 73030 |
|
903 |
845 |
$85K |
| J7050 |
Infusion, normal saline solution, 250 cc |
694 |
626 |
$69K |
| 72100 |
|
1,270 |
1,197 |
$64K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,635 |
6,961 |
$62K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,962 |
2,747 |
$62K |
| 73110 |
|
429 |
397 |
$56K |
| 82947 |
|
357 |
319 |
$42K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,215 |
23,437 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,567 |
2,391 |
$35K |
| 84484 |
|
8,677 |
6,101 |
$35K |
| 86780 |
|
814 |
766 |
$33K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,786 |
6,838 |
$33K |
| 81015 |
|
442 |
411 |
$32K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,109 |
1,047 |
$32K |
| 84702 |
|
1,601 |
1,319 |
$28K |
| 74018 |
|
688 |
643 |
$27K |
| 86756 |
|
171 |
154 |
$27K |
| 93971 |
|
152 |
144 |
$25K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
954 |
879 |
$25K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
409 |
389 |
$24K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,708 |
1,964 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,701 |
4,437 |
$21K |
| 87077 |
|
1,949 |
1,793 |
$19K |
| 83655 |
|
1,027 |
988 |
$17K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,185 |
4,662 |
$15K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
77 |
77 |
$15K |
| 83690 |
|
9,559 |
8,520 |
$14K |
| 83880 |
|
3,572 |
3,012 |
$14K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,428 |
1,356 |
$12K |
| 87807 |
|
391 |
351 |
$12K |
| C1780 |
Lens, intraocular (new technology) |
99 |
93 |
$12K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
976 |
948 |
$12K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
447 |
439 |
$12K |
| 80061 |
Lipid panel |
3,218 |
3,096 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,581 |
9,070 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
95 |
87 |
$10K |
| 87430 |
|
566 |
531 |
$10K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,093 |
2,864 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
851 |
821 |
$9K |
| 85379 |
|
1,139 |
1,072 |
$9K |
| 85027 |
|
3,066 |
2,591 |
$8K |
| 87040 |
|
2,361 |
1,549 |
$8K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
14 |
13 |
$8K |
| 87428 |
|
127 |
124 |
$7K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
168 |
162 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,864 |
2,742 |
$7K |
| 73502 |
|
254 |
242 |
$6K |
| 82728 |
|
451 |
436 |
$5K |
| 73090 |
|
28 |
27 |
$5K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,085 |
995 |
$5K |
| 87150 |
|
208 |
205 |
$5K |
| 84703 |
|
965 |
854 |
$4K |
| 87210 |
|
765 |
704 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
85 |
83 |
$4K |
| 86850 |
|
826 |
748 |
$4K |
| 72050 |
|
61 |
58 |
$4K |
| 84439 |
|
637 |
610 |
$4K |
| 82950 |
|
176 |
171 |
$4K |
| 86738 |
|
47 |
45 |
$3K |
| 86803 |
|
922 |
872 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,770 |
3,413 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,056 |
2,718 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,262 |
1,191 |
$3K |
| 73590 |
|
32 |
30 |
$3K |
| 12001 |
|
12 |
12 |
$3K |
| 93017 |
|
42 |
40 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
845 |
800 |
$2K |
| 83605 |
|
2,537 |
2,058 |
$2K |
| 74022 |
|
233 |
219 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,598 |
920 |
$2K |
| 85610 |
|
2,592 |
2,345 |
$2K |
| 74019 |
|
71 |
68 |
$2K |
| G0378 |
Hospital observation service, per hour |
1,352 |
944 |
$2K |
| 86704 |
|
62 |
47 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,996 |
3,530 |
$2K |
| 82570 |
|
184 |
168 |
$2K |
| 93970 |
|
16 |
16 |
$2K |
| 73564 |
|
25 |
24 |
$2K |
| 86900 |
|
1,300 |
1,164 |
$1K |
| 73140 |
|
15 |
12 |
$1K |
| 84436 |
|
728 |
687 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
15 |
15 |
$1K |
| 86140 |
|
1,425 |
1,272 |
$1K |
| 82077 |
|
1,752 |
1,558 |
$1K |
| 82607 |
|
317 |
307 |
$1K |
| 72070 |
|
13 |
13 |
$1K |
| 73080 |
|
24 |
24 |
$1K |
| 82803 |
|
457 |
375 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,593 |
2,076 |
$1K |
| 76801 |
|
76 |
64 |
$1K |
| 85007 |
|
189 |
176 |
$1K |
| 85652 |
|
349 |
315 |
$935.30 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,656 |
4,820 |
$867.50 |
| 83735 |
|
5,181 |
4,077 |
$841.48 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,421 |
4,950 |
$832.38 |
| 86762 |
|
221 |
196 |
$775.78 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
499 |
172 |
$633.53 |
| 80050 |
General health panel |
15 |
13 |
$630.72 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
14 |
12 |
$627.86 |
| 83540 |
|
306 |
295 |
$607.80 |
| 86787 |
|
260 |
228 |
$584.23 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14 |
12 |
$570.07 |
| 87140 |
|
1,299 |
1,176 |
$517.49 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,778 |
2,277 |
$512.54 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,145 |
3,829 |
$433.55 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
158 |
126 |
$421.22 |
| 94760 |
|
123 |
60 |
$329.85 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
448 |
352 |
$329.85 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
197 |
177 |
$296.92 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,556 |
2,500 |
$276.84 |
| 82550 |
|
818 |
686 |
$256.70 |
| 82043 |
|
95 |
90 |
$250.61 |
| G0659 |
Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes |
361 |
343 |
$192.26 |
| 87340 |
|
623 |
581 |
$178.32 |
| 80143 |
|
28 |
26 |
$152.83 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
941 |
849 |
$132.75 |
| 96376 |
|
190 |
177 |
$32.60 |
| 90715 |
|
297 |
282 |
$28.27 |
| 87186 |
|
2,779 |
2,489 |
$28.02 |
| 85660 |
|
221 |
195 |
$20.35 |
| 86901 |
|
1,299 |
1,163 |
$11.26 |
| 85730 |
|
2,266 |
2,073 |
$10.95 |
| 82553 |
|
571 |
474 |
$6.75 |
| 84132 |
|
13 |
12 |
$3.41 |
| 85014 |
|
20 |
19 |
$2.12 |
| 87205 |
|
189 |
179 |
$2.10 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
280 |
247 |
$1.23 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,999 |
1,520 |
$0.48 |
| J1644 |
Injection, heparin sodium, per 1000 units |
136 |
64 |
$0.24 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,199 |
1,084 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
846 |
770 |
$0.00 |
| J3490 |
Unclassified drugs |
3,331 |
2,417 |
$0.00 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
1,240 |
1,122 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,542 |
1,430 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
310 |
257 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
165 |
145 |
$0.00 |
| 82150 |
|
347 |
316 |
$0.00 |
| A9270 |
Non-covered item or service |
261 |
242 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
143 |
136 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
314 |
283 |
$0.00 |
| 85018 |
|
46 |
44 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
12 |
12 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
75 |
67 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
37 |
25 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12 |
12 |
$0.00 |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
86 |
81 |
$0.00 |
| 86706 |
|
64 |
49 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
68 |
60 |
$0.00 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
13 |
12 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
17 |
16 |
$0.00 |
| 74021 |
|
15 |
13 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
127 |
113 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
134 |
113 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,866 |
2,177 |
$0.00 |
| 80179 |
|
26 |
24 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
322 |
297 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
271 |
145 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
201 |
178 |
$0.00 |
| 84466 |
|
45 |
45 |
$0.00 |
| 84100 |
|
53 |
40 |
$0.00 |
| 85045 |
|
12 |
12 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
13 |
12 |
$0.00 |
| 82397 |
|
16 |
12 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
18 |
12 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
12 |
12 |
$0.00 |